Dendritic Cell Vaccine (DCV)

About Froceth

Froceth is a private, vertically integrated cell therapy company operating in the European advanced therapies space. It develops and manufactures autologous (patient-specific) cell-based products, with a pipeline targeting cancer immunotherapy, multiple sclerosis, and tissue regeneration. The company combines scientific research, clinical trial management, and commercial-scale GMP manufacturing under one roof, positioning itself as a specialized CDMO and therapy developer in a high-growth sector. Its current stage appears to be a mix of pre-clinical/clinical development and commercial service provision.

Therapeutic Areas